<?xml version="1.0" encoding="UTF-8"?>
<p id="Par29">Whilst not the main rationale for its use in COVID-19, the broad antibacterial properties of AZM which is active against a range of gram-positive, gram-negative, anaerobic and atypical infections may reduce secondary infection which were found in 16% of COVID-19 deaths [
 <xref ref-type="bibr" rid="CR23">23</xref>].
</p>
